Tarsus Pharmaceuticals
TARS
$38.24
Share price
-0.88%
Change (1 day)
140.05%
Change (1 year)
Categories
Tarsus Pharmaceuticals (TARS) - Cash on Hand
Cash on Hand as of December 2023 : $0.22 B
According to Tarsus Pharmaceuticals's latest financial reports the company has $0.22 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Tarsus Pharmaceuticals - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.22 B | 4.8% |
| 2022-12-31 | $0.21 B | 26.31% |
| 2021-12-31 | $0.17 B | 2.19% |
| 2020-12-31 | $0.16 B | 190.12% |
| 2019-12-31 | $57.95 M | 2360.81% |
| 2018-12-31 | $2.35 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -8.47% | 🇺🇸 USA |